Yun Chun Li
Chairman en WALVAX BIOTECHNOLOGY CO., LTD. .
Fortuna: 101 M $ al 31/03/2024
Perfil
En la actualidad, Yun Chun Li es presidente de Walvax Biotechnology Co. Ltd. También forma parte del consejo de administración de Shanghai Zerun Biotech Co., Ltd., Genor Biopharma Co., Ltd. y Jiangsu Convac Biotechnology Co., Ltd.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
30/09/2023 | 27 150 181 ( 1.74% ) | 58 M $ | 31/03/2024 | |
30/09/2023 | 20 362 636 ( 43.09% ) | 43 M $ | 31/03/2024 |
Cargos activos de Yun Chun Li
Empresas | Cargo | Inicio |
---|---|---|
WALVAX BIOTECHNOLOGY CO., LTD. | Chairman | 23/06/2009 |
Jiangsu Convac Biotechnology Co., Ltd.
Jiangsu Convac Biotechnology Co., Ltd. BiotechnologyHealth Technology Jiangsu Convac Biotechnology Co., Ltd. engages in the research and development, production, and sale of biological products. It offers new vaccines, genetic modified drugs and in vitro diagnostic reagents. The company was founded on October 13, 2011 and is headquartered in Taizhou, China. | Director/Board Member | - |
Genor Biopharma Co., Ltd.
Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Director/Board Member | - |
Shanghai Zerun Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Director/Board Member | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
WALVAX BIOTECHNOLOGY CO., LTD. | Health Technology |
Empresas privadas | 3 |
---|---|
Shanghai Zerun Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Health Technology |
Genor Biopharma Co., Ltd.
Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Health Technology |
Jiangsu Convac Biotechnology Co., Ltd.
Jiangsu Convac Biotechnology Co., Ltd. BiotechnologyHealth Technology Jiangsu Convac Biotechnology Co., Ltd. engages in the research and development, production, and sale of biological products. It offers new vaccines, genetic modified drugs and in vitro diagnostic reagents. The company was founded on October 13, 2011 and is headquartered in Taizhou, China. | Health Technology |
- Bolsa de valores
- Insiders
- Yun Chun Li